THE BELGIAN OPHTHALMIC ASSOCIATIONS
BRS
Advancing Retina Care: Navigating Biosimilars, Visudyne Accessibility and Hydroxychloroquine retinopathy
AMICO Symposium
Saturday 28 March 2026, 08:30 - 10:00, Room 1
Moderators
Julie DE ZAEYTIJD, Werner DIRVEN
| 08:30 | Welcome by BRS President Dr. Julie De Zaeytijd | |||
| 08:31 | PART 1 - BIOSIMILARS | |||
| 08:31 | Introduction on biosimilars and results of a survey on acceptance of biosimilars in Belgian ophthalmology | CAR E | ||
| 08:50 | Government policy on financing and reimbursement of drugs in medical retina | HOEKX L | ||
| 09:10 | PART 2 - VISUDYNE AVAILABILITY AND BRS ACCESS PROGRAM | |||
| 09:10 | Update on the current Visudyne situation in Belgium | DE ZAEYTIJD J | ||
| 09:20 | Treatment of CSC: When to Use Visudyne - and when not to, in the context of current allocation rules | DE LA PORTE V, SCHAUWVLIEGHE PP | ||
| 09:40 | PART 3 - SCREENING GUIDELINES | |||
| 09:40 | Update on screening guidelines for hydroxychloroquine retinopathy | JACOB J | ||
| 09:59 | Closing Remarks by Dr Werner Dirven | |||
| 10:00 | End of Session | |||